Video
The goals of value-based care are virtually unattainable without alignment of primary and specialty care, hospital and post-acute care, says HSBlox operations chief Lynn Carroll.
The University of Toledo is building and piloting AI models to assist in clinical decision support and to accurately answer patients' and clinicians' questions. Dr. R. Ryan Sadeghian, CMIO and a pediatrician, explains.
AdvancedMD's CEO, Amanda Sharp, explains why a culture of belonging inspires staff before sharing her advice for keeping providers' finances positive in the face of today's cost and reimbursement challenges.
The HIMSS Global Health Conference Education Committee consults attendee feedback and tracks emerging trends to plan its yearly global conference sessions. Committee Chair Michele Krajewski offers a peek inside.
They're used to forecast the longitudinal behavior of trial participants – and by predicting individuals' likely response to a drug, can improve data quality and shorten trial timelines, says Unlearn CEO Steven Herne.
Banner Health's "Text the CEO" program enables patients and visitors to contact executives directly with praise, complaints or other comments regarding their experiences. Amy Adashek-Pinn, senior digital product manager, explains.
Ferdinand Hamada, managing director of the healthcare, pharma and life sciences sector at MorganFranklin Cyber, shows how the current HIPAA rule lays the groundwork for a new forward-looking approach as the stakes are ever higher.
The nation has maintained longitudinal electronic health records for patients since the 1990s, says Ran Balicer, chief innovation officer at Clalit Health Services – which has since enabled clinicians to leverage AI for predictive, proactive care.
Caroline Zago, healthcare informatics leader for Latin America at Philips, says the company leverages AI and machine learning to streamline workflows, make data easier for patients to understand and elevate care quality.
Amprion has partnered with Mayo Clinic Laboratories to expand access to its test, which detects misfolded proteins associated with Parkinson’s, Lewy body dementia, and multiple system atrophy. Russ Lebovitz, the company's CEO, explains.